Sainz-Escarrega VH, Montes de Oca-Morales MG

Language: Spanish
References: 9
Page: 108-110
PDF size: 638.58 Kb.

ABSTRACT

26-years-old male patient diagnosed with infection by Human Immunodeficiency Virus (HIV) onset with pulmonary tuberculosis (TB). In the appointments of control, the patient shows violaceous oral lesions compatible with Kaposi's sarcoma (KS). During the evolution of the patient, the TB disseminates to the pericardium and a treatment with corticosteroids (prednisone) was started. Subsequently, the patient presented a variety of breathing symptoms exacerbation and bilateral interstitial infiltrates, suspecting of dissemination of KS to the lung. The diagnostic is confirmed through a pulmonary biopsy and chemotherapeutic with paclitaxel is initiated. The Kaposi's sarcoma associated with HIV is a multifocal disorder angioproliferative that primarily affects the mucocutaneous tissue with invasion to many organs. Despite the introduction of the highly active antiretroviral treatment, the disease develops in approximately 15% of the patients infected with HIV. The pathogenesis is complex and involves the interaction between herpes virus type 8 (HSV-8), HIV, inflammatory cytokines and angiogenic factors.

REFERENCES

1. Fatahzadeh M. Kaposi sarcoma: review and medical management update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Sep 1. [Epub ahead of print]

2. Taniguchi T, et al. Diseminated cutaneos and visceral Kaposi sarcoma in a patient with rheumatoid arthritis receiving corticosteroids and tacrolimus. Mod Rheumatol 2011;21:309-312

3. Cianfroca M, et al. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human inmunodeficiency virus-associateed Kaposi sarcoma evidence of symptom palliation from chemotherapy. Cancer. 2010 Aug 15;116(16):3969-77.

4. Cattelan A, et al. Novel pharmacological therapies for the treatment of AIDS related Kaposi's Sarcoma. Expert Opin. Invest Drugs 2004;13:501-513

5. Fauci A. Lane C. Enfermedad por VIH: SIDA y trastornos relacionados, Harrison principios de Medicina Interna, 16ª edicicón, México, DF. McGraw-Hill Interamericana (2006) 1194:1264.

6. Feller L, Lemmer J.. Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma. Infect Agent Cancer. 2008 Jan 21;3:1.

7. Dhilon T. Stebbing J. Bower M. Paclitaxel for AIDS-associated Kaposi's Sarcoma. Expert Rev. Anticancer Ther 2005;5(2). 215-219.

8. Sue Jessop. HIV-associates Kaposi's sarcoma. Dermatol Clin 2006;24:509-520.

9. Gill PS, Tulupule A, Espina BM et al. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol. 199917:1876-1883)